TerminatedPhase 2NCT03919162
A Trial to Evaluate the Efficacy and Safety of PQ912 in Patients With Early AD
Studying Early-onset autosomal dominant Alzheimer disease
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Vivoryon Therapeutics N.V.
- Principal Investigator
- Howard FeldmanAlzheimer's Disease Cooperative Study (ADCS)
- Intervention
- PQ912(drug)
- Enrollment
- 112 enrolled
- Eligibility
- 50-89 years · All sexes
- Timeline
- 2021 – 2024
Study locations (22)
- Barrow Neurological Institute, Phoenix, Arizona, United States
- Banner Sun Health Research Institute, Sun City, Arizona, United States
- The Neuron Clinic, Chula Vista, California, United States
- University of California, Irvine, California, United States
- UCSD Alzheimer's Disease Research Center, La Jolla, California, United States
- Cedars-Sinai Center, Los Angeles, California, United States
- PCND Neurology, Poway, California, United States
- Georgetown University Medical Center, Washington D.C., District of Columbia, United States
- USF Health Byrd Alzheimer's Center and Research Institute, Tampa, Florida, United States
- Emory University, Atlanta, Georgia, United States
- Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States
- The University of Iowa Carver College of Medicine, Iowa City, Iowa, United States
- The University of Kentucky Sanders-Brown Center on Aging, Lexington, Kentucky, United States
- Northern Light Acadia Hospital, Bangor, Maine, United States
- NYU Langone Health Tisch Hospital, New York, New York, United States
- +7 more locations on ClinicalTrials.gov
Collaborators
Alzheimer's Disease Cooperative Study (ADCS) · National Institute on Aging (NIA)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03919162 on ClinicalTrials.govOther trials for Early-onset autosomal dominant Alzheimer disease
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT05643144Enhancing Shared Decision-making to Guide Care for People With Dementia and DiabetesIndiana University
- RECRUITINGNANCT07294885Deep Cervical LymphatIc-Venous Anastomosis for Alzheimer's DiseaseGeneral Hospital of Shenyang Military Region
- RECRUITINGNANCT07532590Patients With Pancreatic Tumor: Use of an App to Monitor Progress in a Simple and Intuitive Way by Periodically Completing Targeted Questionnaires and Providing Educational and Informational Content.Casa di Cura Dott. Pederzoli
- ENROLLING BY INVITATIONNCT07314190Retrospective Observational Study of Blood-based Biomarkers in the Diagnosis and Monitoring of Patients With a Neurodegenerative Disease or Mental DisorderFundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
- ENROLLING BY INVITATIONNANCT07425106Comparative Study of High Performance Low-Cost Optical Coherence Tomography (Stage 1B, 2 and 3)Duke University
- RECRUITINGPHASE1NCT07328451A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of DNL628 in Participants With Early Alzheimer's DiseaseDenali Therapeutics Inc.
- RECRUITINGPHASE1NCT07234942A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7812653 in Participants With Early Symptomatic Alzheimer's Disease (eAD)Hoffmann-La Roche
- RECRUITINGNCT07207642Sweet Night (Musical Diffusion by Caregivers ): Effects of Musical Diffusion by Caregivers on Sleep Onset and Behavioral Regulation in a Protected LivingCentre Hospitalier Universitaire de Saint Etienne
See all trials for Early-onset autosomal dominant Alzheimer disease →